Business Wire
11 Nov 2025, 23:00 UTC · 46w ago
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
Verdict
Headline leans bearish. We score AMLX −0.80.
Score confirms the headline.
- Headline says
Leans bearish
From its wording — no explicit rating
- Expected · AMLX
−0.80strongly bearish





